{"id":"https://openalex.org/W4387617975","doi":"https://doi.org/10.3390/hematolrep15040060","title":"Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment","display_name":"Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment","publication_year":2023,"publication_date":"2023-10-13","ids":{"openalex":"https://openalex.org/W4387617975","doi":"https://doi.org/10.3390/hematolrep15040060","pmid":"https://pubmed.ncbi.nlm.nih.gov/37873795","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10594490"},"language":"en","primary_location":{"id":"doi:10.3390/hematolrep15040060","doi":"https://doi.org/10.3390/hematolrep15040060","is_oa":true,"landing_page_url":"https://doi.org/10.3390/hematolrep15040060","pdf_url":"https://www.mdpi.com/2038-8330/15/4/60/pdf?version=1697190001","source":{"id":"https://openalex.org/S171672039","display_name":"Hematology Reports","issn_l":"2038-8322","issn":["2038-8322","2038-8330"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2038-8330/15/4/60/pdf?version=1697190001","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018935336","display_name":"Jesse Fishman","orcid":"https://orcid.org/0009-0002-8729-7435","observed_orcids":["https://orcid.org/0009-0002-8729-7435"]},"institutions":[{"id":"https://openalex.org/I4210120540","display_name":"Apellis Pharmaceuticals (United States)","ror":"https://ror.org/0231n7e68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120540"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse Fishman","raw_affiliation_strings":["Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA"],"raw_orcid":"https://orcid.org/0009-0002-8729-7435","affiliations":[{"raw_affiliation_string":"Apellis Pharmaceuticals, Inc., Waltham, MA 02451, USA","institution_ids":["https://openalex.org/I4210120540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044599824","display_name":"Seri Anderson","orcid":"https://orcid.org/0000-0001-7765-6399","observed_orcids":["https://orcid.org/0000-0001-7765-6399"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Seri Anderson","raw_affiliation_strings":["RTI Health Solutions, Research Triangle Park, NC 27709, USA"],"raw_orcid":"https://orcid.org/0000-0001-7765-6399","affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085964220","display_name":"Sandra E. Talbird","orcid":"https://orcid.org/0000-0003-4719-3703","observed_orcids":["https://orcid.org/0000-0003-4719-3703"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra E. Talbird","raw_affiliation_strings":["RTI Health Solutions, Research Triangle Park, NC 27709, USA"],"raw_orcid":"https://orcid.org/0000-0003-4719-3703","affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Research Triangle Park, NC 27709, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007747233","display_name":"David Dingli","orcid":"https://orcid.org/0000-0001-7477-3004","observed_orcids":["https://orcid.org/0000-0001-7477-3004"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Dingli","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044599824"],"corresponding_institution_ids":["https://openalex.org/I4210120329"],"apc_list":{"value":1600,"currency":"CHF","value_usd":1779},"apc_paid":{"value":1600,"currency":"CHF","value_usd":1779},"fwci":0.6547,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.63411505,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"15","issue":"4","first_page":"578","last_page":"591"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":1.0},{"id":"https://openalex.org/keywords/pegcetacoplan","display_name":"pegcetacoplan","score":0.9399999976158142},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":1.0},{"id":"https://openalex.org/keywords/suboptimal-response","display_name":"suboptimal response","score":0.6050000190734863},{"id":"https://openalex.org/keywords/complement-inhibitors","display_name":"complement inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.5640000104904175},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pegasus-trial","display_name":"PEGASUS trial","score":0.8309999704360962},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.907809853553772},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8977261781692505},{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.886617124080658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46859967708587646},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.4455556869506836},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4142843186855316},{"id":"https://openalex.org/C2778639011","wikidata":"https://www.wikidata.org/wiki/Q1553850","display_name":"Hemoglobinuria","level":3,"score":0.41376420855522156},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23069238662719727},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.230046808719635},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.13617771863937378},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.09319281578063965}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/hematolrep15040060","doi":"https://doi.org/10.3390/hematolrep15040060","is_oa":true,"landing_page_url":"https://doi.org/10.3390/hematolrep15040060","pdf_url":"https://www.mdpi.com/2038-8330/15/4/60/pdf?version=1697190001","source":{"id":"https://openalex.org/S171672039","display_name":"Hematology Reports","issn_l":"2038-8322","issn":["2038-8322","2038-8330"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10594490","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10594490","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10594490/pdf/hematolrep-15-00060.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematol Rep","raw_type":"Text"},{"id":"pmid:37873795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37873795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:fce0e3528a4c4be388e607a378d91875","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/fce0e3528a4c4be388e607a378d91875","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology Reports, Vol 15, Iss 4, Pp 578-591 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/hematolrep15040060","doi":"https://doi.org/10.3390/hematolrep15040060","is_oa":true,"landing_page_url":"https://doi.org/10.3390/hematolrep15040060","pdf_url":"https://www.mdpi.com/2038-8330/15/4/60/pdf?version=1697190001","source":{"id":"https://openalex.org/S171672039","display_name":"Hematology Reports","issn_l":"2038-8322","issn":["2038-8322","2038-8330"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319069","display_name":"Apellis Pharmaceuticals","ror":"https://ror.org/0231n7e68"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387617975.pdf","grobid_xml":"https://content.openalex.org/works/W4387617975.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1978700432","https://openalex.org/W2023377972","https://openalex.org/W2081653014","https://openalex.org/W2130696459","https://openalex.org/W2152757679","https://openalex.org/W2171068466","https://openalex.org/W2285334580","https://openalex.org/W2519603001","https://openalex.org/W2902552969","https://openalex.org/W2903198260","https://openalex.org/W2951566892","https://openalex.org/W2972737609","https://openalex.org/W2985220877","https://openalex.org/W2985611003","https://openalex.org/W3081542742","https://openalex.org/W3094891764","https://openalex.org/W3117734283","https://openalex.org/W3136167138","https://openalex.org/W3164463835","https://openalex.org/W3179808504","https://openalex.org/W3184889104","https://openalex.org/W3211813768","https://openalex.org/W4205593330","https://openalex.org/W4283008478","https://openalex.org/W4283332533","https://openalex.org/W4286587544","https://openalex.org/W4293708359","https://openalex.org/W4296028088","https://openalex.org/W4309280962","https://openalex.org/W4322489436"],"related_works":["https://openalex.org/W3217433566","https://openalex.org/W7121450798","https://openalex.org/W4386347859","https://openalex.org/W4417479755","https://openalex.org/W4413781026","https://openalex.org/W6920619936","https://openalex.org/W3198044899","https://openalex.org/W3094891764","https://openalex.org/W4376872020","https://openalex.org/W4284670301"],"abstract_inverted_index":{"European":[0],"Society":[1],"for":[2,52,104],"Blood":[3],"and":[4,54,60,75,112,124,157,171,189],"Marrow":[5],"Transplantation":[6],"(EBMT)":[7],"hematologic":[8],"response":[9,50,63,139,207,212,224],"categories":[10],"comprehensively":[11],"assess":[12],"complement":[13,186],"inhibitor":[14],"responses":[15],"in":[16,56],"patients":[17,129,203,220],"with":[18,58,155,160,181,194,204,221],"paroxysmal":[19],"nocturnal":[20],"hemoglobinuria":[21],"(PNH).":[22],"Using":[23],"data":[24],"from":[25,197],"the":[26,32,42,48,87],"16-week":[27],"randomized":[28],"controlled":[29],"period":[30],"of":[31,117,126],"phase":[33],"3":[34],"PEGASUS":[35],"trial":[36,88],"(N":[37],"=":[38],"80),":[39],"we":[40],"estimated":[41,82],"treatment":[43,108,228],"cost":[44],"per":[45,69,79,149,166,178],"responder":[46,80,151,180],"by":[47],"EBMT":[49],"category":[51],"pegcetacoplan":[53,123,156,182,200],"eculizumab":[55,132,198,227],"adults":[57],"PNH":[59],"a":[61,134,205,210,222],"suboptimal":[62,206,223],"to":[64,73,122,199,208,219,225],"eculizumab.":[65,195],"Average":[66,145,175],"drug":[67,77,147,164,176],"costs":[68,78,148,165,177],"responder,":[70],"number":[71],"needed":[72],"treat,":[74],"incremental":[76],"were":[81,102,152,168,183,190],"using":[83],"dosages":[84],"administered":[85],"during":[86],"(base":[89],"case).":[90],"A":[91],"US":[92,96],"payer":[93],"perspective":[94],"(2020":[95],"dollars)":[97],"was":[98],"used.":[99],"Scenario":[100],"analyses":[101],"conducted":[103],"various":[105],"costs,":[106],"dosages,":[107],"durations,":[109],"patient":[110,167],"populations,":[111],"settings.":[113],"In":[114],"total,":[115],"30":[116],"41":[118],"(73%)":[119],"who":[120,130],"switched":[121],"2":[125],"39":[127],"(5%)":[128],"continued":[131],"had":[133],"good,":[135],"major,":[136],"or":[137],"complete":[138],"(good-to-complete":[140],"responders)":[141],"at":[142,213],"Week":[143],"16.":[144],"weekly":[146,163],"good-to-complete":[150,179,211],"USD":[153,158,169,172],"15,923":[154],"216,100":[159],"eculizumab;":[161],"average":[162],"11,651":[170],"11,082,":[173],"respectively.":[174],"similar":[184],"across":[185],"inhibitor-na\u00efve":[187],"populations":[188],"consistently":[191],"lower":[192,214],"than":[193],"Switching":[196],"allowed":[201],"more":[202],"attain":[209],"costs.":[215],"These":[216],"results":[217],"apply":[218],"prior":[226],"only.":[229]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-10-14T00:00:00"}